Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IOV-4001 |
Trade Name | |
Synonyms | IOV 4001|IOV4001 |
Drug Descriptions |
IOV-4001 are autologous tumor infiltrating lymphocytes engineered to knockout PD-1 (PDCD1), which potentially increase antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187652 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IOV-4001 | IOV-4001 | 0 | 1 |